Legal Representation
Attorney
G PATRICK SAGE II
USPTO Deadlines
Next Deadline
1980 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-01-07)
Due Date
January 07, 2031
Grace Period Ends
July 07, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
30 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 26, 2025 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
Jul 3, 2025 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
Jul 3, 2025 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
Apr 7, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
Jan 7, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Jan 7, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Nov 23, 2024 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
Nov 6, 2024 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
Nov 6, 2024 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
Sep 17, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Sep 17, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Aug 28, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Aug 14, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Aug 14, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Aug 14, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Aug 14, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Aug 14, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Aug 12, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Aug 12, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Aug 12, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Mar 4, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
Feb 12, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
Feb 12, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
Jan 28, 2024 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
Jan 25, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
Jan 24, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jan 24, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jun 16, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
Jun 12, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jun 8, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Chemicals used in industry and science; biological preparations for use in industry and science.
Class 005
Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, oncological, hepatological, ophthalmic respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; sanitary preparations for medical purposes; dietetic food and substances adapted for medical use, food for babies; dietary supplements for human beings; plasters for medical purposes, materials for dressings, namely gauze, natural or synthetic bandages and medical cotton wools; material for stopping teeth and dental wax; disinfectants
Class 042
Scientific research and design relating to medical research; chemical research; pharmaceutical research services; development of pharmaceutical preparations and medicines; clinical tests, namely, conducting clinical trials in the fields of pharmaceuticals.
Class 044
Medical services; hygiene and beauty care for humans; pharmaceutical dispensary services, namely, preparation of prescriptions in pharmacies; human healthcare services; providing medical information; pharmaceutical consultancy; consultancy and information services relating to use of pharmaceutical products; medical and pharmaceutical consultation services.
Classification
International Classes
001
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"HEALTHCARE"